{
    "2021-02-08": [
        [
            {
                "time": "",
                "original_text": "因可转换债券获转换 药明康德(02359)发行98232股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "可转换债券",
                        "发行"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "「医药速读社」阿斯利康Imfinzii3期临床失败 凯因科技科创板上市 产品问题",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "临床失败",
                        "凯因科技",
                        "科创板上市"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：第四批国采结果公布 长期看好创新与高景气细分领域",
                "features": {
                    "keywords": [
                        "医药生物",
                        "国采",
                        "创新",
                        "高景气"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：积极关注新冠疫苗进展 持续拥抱差异化赛道",
                "features": {
                    "keywords": [
                        "医药",
                        "新冠疫苗",
                        "差异化赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业深度报告：CDMO行业进入黄金发展阶段 龙头企业竞争优势凸显",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CDMO",
                        "黄金发展",
                        "龙头企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "万和证券：药明康德(603259)2020年业绩增长强劲，维持“买入”评级",
                "features": {
                    "keywords": [
                        "药明康德",
                        "业绩增长",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2年7倍光伏龙头突曝大消息，股东“甩卖”158亿",
                "features": {
                    "keywords": [
                        "光伏",
                        "龙头",
                        "减持",
                        "甩卖"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "岂止社保减持！更有多只千亿大牛股被抛售，什么信号 减持股份",
                "features": {
                    "keywords": [
                        "社保减持",
                        "大牛股",
                        "抛售"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：第二款国产新冠疫苗获批上市 看好疫苗大时代背景下的新冠增量",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠疫苗",
                        "获批上市",
                        "增量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：第四批集采落地 持续看好创新及相关产业链CXO",
                "features": {
                    "keywords": [
                        "医药",
                        "集采",
                        "创新",
                        "CXO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "无锡药明康德新药开发股份有限公司 在美国纳斯达克证券交易所挂牌上市的公告",
                "features": {
                    "keywords": [
                        "药明康德",
                        "纳斯达克",
                        "上市"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}